Wednesday didn’t bring a boring report, but a nutra rollercoaster: 17 networks fired off, offers got dumped in by the truckload, and in some places payouts got juiced so hard it made the calculator blush.
🎯 Shivital went full vitamin takedown
Shivital didn’t just grow today — it straight-up handed out hope in bulk: BE diabetes from 20 to 50 (+150%), CZ parasites also 20→50, IT diabetes 20→48. The whole lineup looks like it decided to treat at premium rates — and skip the queue.
💸 Shakes and AdCombo slapped on the markup without shame
In Shakes DE, two payouts got a makeover at once: Shivital DE diabetes and Cystolax DE cystitis moved out of the 20–40 range into 70–80 — that’s not an update anymore, that’s nutra on steroids. Shakes RO also climbed: Shivital RO diabetes/vision from 20 to 35. AdCombo kept it more modest worldwide: NIAPEPT and Omnilar from 19.5–21 to 25–26.
🧪 New offers were raining down like capsules out of a shaker
LemonAD clearly didn’t sleep today: Slimlex GLP-1, KetoNex Gummies, GlucoLife+, Arthro MD+, MANERGY, PEAK STATE, PRIME MAN — a lineup big enough to build your own affiliate first-aid kit for everything from joints to male confidence. Also there: Cystanox and Urivelle for GE — because apparently that GEO refuses to be boring.
🧊 MetaCPA and Shakes didn’t miss out on the fresh stuff either
Notable drops: Noxivam for PL in MetaCPA, and Shakes FI landed two newcomers at once — Reishield lungs and Reishield neuropathy. Yeah, when nutra decides to head to Finland, it goes there with calm determination and a very heavy name.
🪓 Pulls: the market got cleaned out with zero mercy
Out went Ophtalax, Hypotenol, Prostavec, Uro UP Forte Prostatitis at SkyLead, and T-Light cleared out an entire closet: from Handy Heater and Yasam to Magic Brush, Massage Gun, and the rest of the home-circus stock. Today товарка switched to “we’ll sort it out later” mode — but without it, things do feel a lot less cozy.
📉 Veneers eased off a bit, but nothing dramatic
Snap-On Smile in Greece slipped from 14 to 11 (-21%) — a rare case where the smile got just a little less golden. The offer’s targets also went down: +3/−6 by GEO, so dentistry is off the fanfare today, but the math is honest.
🚀 Aray came in with a bang
Aray debuted with +198 offers right out of the gate. The newcomer didn’t do the shy little “let me try it first” routine — it showed up to take over half the catalog. That kind of entrance usually means one thing: either the catalog comes alive fast, or everyone else has to scoot over and pretend that was the plan all along.